12:00 AM
Sep 24, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Flunisyn: Phase I data

Data from a pair of double-blind Phase I trials showed that Flunisyn produced T cell responses that were able to recognize multiple strains of influenza A. The first Phase...

Read the full 121 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >